Insider Buying: NexgenRx Inc. (NXG) Insider Acquires 110,500 Shares of Stock

NexgenRx Inc. (TSE:NXG) insider Paul Everett Crossett purchased 110,500 shares of NexgenRx stock in a transaction on Friday, February 10th. The shares were acquired at an average cost of C$0.24 per share, for a total transaction of C$26,520.00.

Paul Everett Crossett also recently made the following trade(s):

  • On Thursday, February 9th, Paul Everett Crossett purchased 15,000 shares of NexgenRx stock. The stock was bought at an average price of C$0.26 per share, with a total value of C$3,900.00.
  • On Friday, February 3rd, Paul Everett Crossett purchased 16,500 shares of NexgenRx stock. The stock was bought at an average price of C$0.25 per share, with a total value of C$4,125.00.
  • On Wednesday, February 1st, Paul Everett Crossett purchased 22,500 shares of NexgenRx stock. The stock was bought at an average price of C$0.25 per share, with a total value of C$5,625.00.
  • On Monday, January 30th, Paul Everett Crossett purchased 500 shares of NexgenRx stock. The stock was bought at an average price of C$0.23 per share, with a total value of C$115.00.
  • On Friday, January 27th, Paul Everett Crossett purchased 20,000 shares of NexgenRx stock. The stock was bought at an average price of C$0.23 per share, with a total value of C$4,600.00.
  • On Monday, January 23rd, Paul Everett Crossett purchased 5,000 shares of NexgenRx stock. The stock was bought at an average price of C$0.23 per share, with a total value of C$1,150.00.
  • On Tuesday, January 24th, Paul Everett Crossett purchased 20,000 shares of NexgenRx stock. The stock was bought at an average price of C$0.23 per share, with a total value of C$4,600.00.

Insider Buying and Selling by Quarter for NexgenRx (TSE:NXG)

TRADEMARK VIOLATION WARNING: “Insider Buying: NexgenRx Inc. (NXG) Insider Acquires 110,500 Shares of Stock” was first reported by sleekmoney and is the property of of sleekmoney. If you are viewing this piece on another domain, it was illegally stolen and republished in violation of US & international copyright and trademark legislation. The correct version of this piece can be viewed at http://sleekmoney.com/insider-buying-nexgenrx-inc-nxg-insider-acquires-110500-shares-of-stock/1655088.html.

NexgenRx Company Profile

NexgenRx Inc (NexgenRx) administers, adjudicates and pays drug, dental and other extended healthcare claims for the beneficiaries of health benefit plans underwritten by its customers, using computer software. The Company is engaged in the sale of its administration and health benefit claims adjudication services to organizations managing health benefit plans on behalf of plan sponsors, such as employers and associations, among others, and to the Canadian plan sponsors providing an Administrative Services Only (ASO) health benefit plan to their plan members.

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/insider-buying-nexgenrx-inc-nxg-insider-acquires-110500-shares-of-stock/1655088.html

Receive News & Ratings for NexgenRx Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NexgenRx Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *